stockrowHims & Hers Health, Inc. (HIMS) vs Liquidia Corporation (LQDA)
- Hims & Hers Health, Inc. HIMS 24.11 −9.56%
- Liquidia Corporation LQDA 44.69 −5.68%
Hims & Hers Health, Inc. and Liquidia Corporation are both Drug Manufacturers Specialty & Generic companies. Hims & Hers Health, Inc. is the larger, with a market value of $5.6B against $4.0B — 1.4× the size. Hims & Hers Health, Inc. has negative trailing earnings, so its P/E is not meaningful; Liquidia Corporation trades at 28.5×. Liquidia Corporation grew revenue faster over the last twelve months: 2,233.7% against 28.0%. Liquidia Corporation has the higher net margin (30.7% vs −5.51%) and the higher return on invested capital (121.1% vs −11.4%). Across the 19 metrics below, Liquidia Corporation leads on 16 and Hims & Hers Health, Inc. on 3.
Valuation
Profitability
| Metric | HIMS | LQDA | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 68.43% | 92.54% | 53.51% |
| Operating margin | (5.99%) | 37.39% | 0.00% |
| Net margin | (5.51%) | 30.74% | (2.45%) |
| Free cash flow margin | 3.22% | 33.42% | 0.00% |
| Return on equity | (32.03%) | 131.82% | (0.80%) |
| Return on assets | (5.16%) | 35.57% | (1.67%) |
| Return on invested capital | (11.38%) | 121.05% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack